SID Annual Meeting
2020-05-13 07:00:00
  • Home
    • Donate
  • Information
    • Claim your CME credits
    • Meeting Link, Program & Attendee User Guides
    • Abstract Book(s)
    • 2021 Meeting FAQ’s
    • Registration
    • Confirmed Speakers/Awardees
    • Poster/Exhibit Hall Information
    • 2021 Confirmed Exhibitors/Partners
    • Associate Group Programming
    • 2021 Registration Grants Information
    • Scientific Program Committee
    • Future Annual Meetings
  • Abstracts
    • 2021 Abstract Submission
      • Late-Breaking Abstract Submission
    • Abstract Categories
    • 2021 Abstract Outcomes
    • Presentation Information
  • Mon. 5/3
  • Tues. 5/4
  • Wed. 5/5
  • Thurs. 5/6
  • Fri. 5/7
  • Sat. 5/8
  • Home
    • Donate
  • Information
    • Claim your CME credits
    • Meeting Link, Program & Attendee User Guides
    • Abstract Book(s)
    • 2021 Meeting FAQ’s
    • Registration
    • Confirmed Speakers/Awardees
    • Poster/Exhibit Hall Information
    • 2021 Confirmed Exhibitors/Partners
    • Associate Group Programming
    • 2021 Registration Grants Information
    • Scientific Program Committee
    • Future Annual Meetings
  • Abstracts
    • 2021 Abstract Submission
      • Late-Breaking Abstract Submission
    • Abstract Categories
    • 2021 Abstract Outcomes
    • Presentation Information
  • Mon. 5/3
  • Tues. 5/4
  • Wed. 5/5
  • Thurs. 5/6
  • Fri. 5/7
  • Sat. 5/8
Akiko Iwasaki is seen on Friday April 26 2013 at Yale University. (Kike Calvo/AP Images for HHMI)

Julius Stone Lecturer

Akiko Iwasaki, PhD

Yale School of Medicine

Title:  Immune Responses to SARS-CoV-2

Professor Akiko Iwasaki has made major discoveries in innate anti-viral and mucosal immunity that have resulted in paradigm shifts in the understanding of the immune response to pathogens as well as in vaccine design.  Her research focuses on the mechanisms of immune defense against viruses at mucosal surfaces, which are a major site of entry for infectious agents. The knowledge gained in her lab can be used to design more effective vaccines or microbicides to prevent transmission of viral and bacterial pathogens.

Professor Iwasaki’s research group developed a new vaccine strategy, termed “Prime and Pull”, that can be used to treat those infected with virus, unlike many vaccines that are given preventatively. This method is currently under phase 2 clinical trials for the treatment of high grade cervical lesions caused by infection human papillomavirus (HPV).

Professor Iwasaki received her Ph.D. in Immunology from the University of Toronto and completed her postdoctoral training with the National Institutes of Health before joining Yale’s faculty in 2000. She has received numerous awards and honors, including the Burroughs Wellcome Fund Career Award in Biomedical Sciences, the Wyeth Lederle Young Investigator Award, the BD Biosciences Investigator Award, and the Seymour & Vivian Milstein Award for Excellence in Interferon and Cytokine Research. Professor Iwasaki has been a Howard Hughes Medical Institute Investigator since 2014, a prestigious honor that provides the researcher long-term, flexible funding that gives them to freedom to explore new avenues of research. She was elected to the National Academy of Sciences in 2018, and to the National Academy of Medicine in 2019. Dr. Iwasaki is also well known for her Twitter advocacy on women and underrepresented minority in the science and medicine fields.

Currently, Professor Iwasaki is directing translational immunology team to investigate the role of immune response in COVID-19 disease outcome. She also co-directs the IMPACT (Implementing medical and public health actions against coronavirus in Connecticut) team to generate an extensive biorepository for specimens collected from patients and health care workers, as well as implementing viral testing in both groups.

https://medicine.yale.edu/profile/akiko_iwasaki/

https://medicine.yale.edu/lab/iwasaki/

 

About the Lecture:

The Julius Stone Lectureship is intended to promote the advancement of knowledge in immunology as its relates to the skin and skin disease.  The Lectureship is also intended to honor Dr. Julius Stone, whose great commitment to the application of new principles of immunology to the benefit of patients with skin disorders is recognized by this award.

Other Speakers

NHSportrait-fix-1Herman Beerman Lecturer
Dan Kaplan~low resWilliam Montagna Lecturer
Version 2Eugene M. Farber Lecturer
2021 Meg ChrenNaomi M. Kanof Lecturer
Paul Khavari Photo for RothmanStephen Rothman Memorial Awardee
OH, JuliaState-of-the-Art Plenary Lecture I
YH_officeState-of-the-Art Plenary Lecture II
brownell-hi resState-of-the-Art Plenary Lecture III
Donald_Glass_headshotState-of-the-Art Plenary Lecture IV
VUMC employee headshots on January 11, 2021. Photos by Donn Jones/Vanderbilt University Medical CenterState-of-the-Art Plenary Lecture V
Shuai Xu MD ~ hi resState-of-the-Art Plenary Lecture VI
MTO-Stuart IsettSpecial Guest Speaker
SID_logo_PPlenary Sessions I-IV
Twitter Highlights
  • LEO Foundation Award deadline extended to January 29! https://t.co/eNkZQqeJ51
    1 day ago
  • RT @ISID2023Tokyo: Calling young skin scientists! LEO Foundation Award 2023 Self-nomination deadline is 25 Jan. https://t.co/8YAwc9OhJs Awa…
    9 days ago

Follow SID on Twitter

© 2021 Society for Investigative Dermatology, All rights reserved.